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The aim of this study was to evaluate the influence of culture medium on dose-response effect of chlorhexidine (CHX) on
Streptococcus mutans UA159 biofilm and validate the use of the cation-adjusted-Mu¨ller-Hinton broth (MH) for the evaluation
of antibacterial activity. Ultrafiltered Tryptone-Yeast Extract Broth (UTYEB) was compared against MH and MH with blood
supplementation (MHS). For each medium, six groups (𝑛 = 4) were assessed: two negative control groups (baseline 48 and 120 h)
and four experimental groups (0.0001, 0.001, 0.012, and 0.12%CHX). S.mutans biofilm grew on glass slides of eachmedia containing
1% sucrose. After 48 h of growth, biofilms of baseline 48 h were collected and the other groups were treated for 1min, twice a day, for
3 days, with their respective treatments. The media were changed daily and pH was measured. After 120 h, biofilms were collected
and dry weight and viablemicroorganisms were determined. Results showedCHXdose-response effect being observed in all media
for all the variables. However, MH and MHS showed higher sensitivity than UTYEB (𝑝 < 0.05). We can conclude that the culture
medium does influence dose-response effect of CHX on Streptococcus mutans biofilm and that MH can be used for antibacterial
activity.
1. Introduction
Streptococcus mutans, primary etiological agent of dental
caries in animals and humans, is also involved in biofilm
formation and accumulation [1]. It is considered the most
implicatedmicroorganism in dental caries [2, 3] as it presents
acidogenic and aciduric properties as well as having the
ability to survive, grow, and maintain its metabolism under
acidic conditions [4].Therefore, S. mutans biofilms have been
used in in vitro tests to evaluate cariogenic properties due to
difficulties of developing in vivo studies for controlled cario-
genic situations [5]. This microorganism is able to produce
extracellular polysaccharide (EPS) from dietary carbohy-
drates, especially sucrose, that has been considered the most
cariogenic carbohydrate [6], once it is the main substrate
of cariogenic bacteria to synthesize EPS [7]. Extracellular
polysaccharides improve bacterial adherence to tooth sur-
faces and modifies the biofilm matrix [8], increasing the
porosity of dental biofilm matrix by the presence of these
insoluble glucans [9, 10], facilitating the installation of caries
disease [11, 12] and the shift in biofilmmicrobiota induced by
pH fall [13], resulting in equilibrium disturbance of biofilm
and tooth.
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Chlorhexidine (CHX) is the most studied and effective
antimicrobial agent in the chemical control of dental plaque,
being considered the positive control (gold standard), to
which all other antiplaque agents should be compared to
[14]. It is a cationic bis-biguanide, with a wide antibacterial
activity, low mammalian cells toxicity, and a high affinity to
attach to skin and mucous membranes. Its mechanism of
action includes direct damage to the internal cytoplasmatic
membrane, being bacteriostatic at low doses and bactericidal
at high concentrations. Its advantages are not only based on
its antimicrobial properties but also on its affinity to attach to
a wide variety of substrates.This property, known as substan-
tivity, allows this compound to attain effective antibacterial
levels, using a reasonable dosage (twice a day), thus allowing
patients to comply with its use [15].
The potential of oral antimicrobials was usually evalu-
ated in classical Minimum Inhibitory Concentration (MIC)
and Minimum Bactericidal Concentration (MBC) tests,
using planktonic monocultures and prolonged exposure to
mouthrinses. In comparison with clinical tests the resulting
inhibitory concentrations were 100–1000 times lower [16].
However, bacteria growing as a biofilm on a surface show
reduced sensitivity to killing by antimicrobials, especially
in older (more mature) biofilms. The reasons for this vary
among inhibitors but include (a) reduced penetration of the
agent, for example, due to binding to the biofilm matrix or
quenching of the agent at biofilm surface, (b) the novel phe-
notype expressed by bacteria when growing on a surface, and
(c) the slow growth rates of attached bacteria within biofilms
[17].
Thus, they allowed only relative comparisons and were
poorly predictive of the clinical efficacy of antiseptics. In vitro
studies of dental biofilms models have been developed to
mimicwhat occurs in the oral environment.However, there is
not, in literature, a standardization regarding the used culture
medium, which can be relevant to determine the relation
dose-effect antimicrobial activity. Conversely, the nutrient
medium content was found to regulate the development of
biofilms in several organisms [18–20]. Therefore, the aim of
this study was to evaluate the influence of culture medium on
dose-response effect of the chlorhexidine, gold standard, on S.
mutans biofilm model using cation-adjusted-Mu¨ller-Hinton
broth (MH) medium, as indicated by CLSI M7-A6 [21] for
planktonic cells, with or without lysed horse blood [21], to
validate the use of the MH culture media.
2. Material and Methods
2.1. Experimental Design. This S. mutans biofilm model was
a modified version detailed by Koo et al. [22] and Ccahuana-
Va´squez and Cury [23], using culture medium and inoculum
prepared as indicated by CLSI M7-A6 [21]. S. mutans UA159
biofilms were formed on glass microscope slides (Corning
Incorporated, New York, USA), suspended vertically in
Ultrafiltered (10 kDa molecular weight cut-off membrane;
Amicon) Tryptone-Yeast Extract Broth (UTYEB) [22], or
cation-adjusted-Mu¨ller-Hinton broth (Sigma-AldrichCo., St.
Louis, MO, USA) with or without lysed horse blood (MHS
or MHS, resp.) [21], all containing 1% sucrose, at 37∘C, 10%
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Figure 1: (a) Glass microscope slides. (b) Glass microscope slides
on medium culture in the culture plates.
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for 5 days. After 48 h one group of biofilm (baseline 48 h)
was collected and the other groups were treated by 1min,
twice a day, with the respective solutions, for 3 days: group
2, 0.9% NaCl (Baseline 120 h) (𝑛 = 4); group 3, CHX 1 𝜇g/mL
(0.0001%) (𝑛 = 4); group 4, CHX 10 𝜇g/mL (0.001%) (𝑛 = 4);
group 5, CHX 120𝜇g/mL (0.012%) (𝑛 = 4); group 6, CHX
1.200𝜇g/mL (0.12%) (𝑛 = 4).The biomass and viable bacteria
of biofilms were determined and the culture medium pHwas
determined daily, as an indicator of biofilm acidogenicity.The
determination of the pHmedium of groups 2 to 6 was carried
out directly on the plate, with a calibrated pH meter and
controlled environment.
2.2. Glass Slides Preparation. Glass microscope slides (Corn-
ing Incorporated, New York, USA) were cut to obtain slides
with 10 × 5 × 1mm (Figure 1(a)). Glass slides were autoclaved,
anchored vertically with metal devices, and suspended in a
24-well culture plate (Figure 1(b)).
2.3. Biofilm Growth. Ultrafiltered Tryptone-Yeast Extract
Broth (UTYEB) [22] or MH or MHS (CLSI M7-A6) [21] was
used as culture medium as described as follows.
When UTYEB medium was used, S. mutans UA159
colonies (5–10) were transferred to UTYEB containing 1%
glucose and incubated for 18–24 h, at 37∘C and 10% CO
2
to
reactivate the microorganisms. 100𝜇L of the suspension was
mixed with 50mL of UTYEB containing 1% sucrose to obtain
a final inoculum concentration of 5 × 105 CFU/mL (colony
forming unit/milliliter) [23].
When theMHmediumwas used (with orwithout blood),
S. mutans UA159 colonies were transferred for a blood agar
plate and it was incubated by 18–24 h, at 37∘C and 10% CO
2
adjusted to a McFarland 0.5 to 0.63 in saline solution, 0.9%
corresponding to 5 × 108 CFU/mL. 125𝜇L of this inoculum
was added to 50mL of MH containing 1% sucrose, in
order to obtain a final concentration of 5 × 105 CFU/mL, as
recommended by CLSI M7-A6 [21].
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The glass slides were individually positioned in wells
containing 2.0mL of the inoculum and were incubated at
37∘C and 10% CO
2
to allow bacterial adhesion. On the next
day, the biofilms formed on glass slides were transferred to
fresh medium containing 1% sucrose. This procedure was
repeated for the next 3 days. The pH of the culture medium
was determined daily as an indicator of biofilm acidogenicity.
2.4. Treatments. CHX solutions were prepared from 20%
chlorhexidine digluconate (Sigma-Aldrich Co., St. Louis,
MO, USA) in sterilized distilled water to obtain concen-
trations of 0.0001, 0.001, 0.012, and 0.12% CHX, since it
was previously verified that the CHX’s Minimum Inhibitory
Concentration (MIC) against S. mutans UA 159 is 1 𝜇g/mL
(0.0001%) (CLSI M7-A6, 2003 [21]) (unpublished results).
Treatments were performed twice a day and after each
treatment, the biofilms formed on glass slides were washed
3 times in 0.9% NaCl.
2.5. Biofilm Collection. After the assigned experimental time
of biofilm growth, the microscope glass slides containing
biofilms were washed 3 times in 0.9% NaCl and individually
transferred to microcentrifuge tubes containing 1mL of 0.9%
NaCl.
The tubes were sonicated at 7W for 30 s (Branson,
Sonifier 50, Danbury, CT,USA) to detach the biofilms formed
on the microscope glass, according to Aires et al. [24]. The
glass slides were carefully removed from the suspension and
discarded. Aliquots of the suspension were used to determine
biofilm bacterial viability and biomass (dry weight).
2.6. Biomass Determination. Biofilm dry weight was deter-
mined according to Koo et al. [22] from 200𝜇L of the
suspension. For the dry weight determination, three volumes
of cold ethanol (−20∘C) were added to cell suspension, and
the resulting precipitate was collected (10 000 g for 10min,
4∘C). The supernatant was discarded, and the cell pellet was
washed twice with cold ethanol, dried, and had the weight
checked.
2.7. Bacterial Viability. An aliquot of 100 𝜇L of the suspension
formed after sonication was diluted in 0.9%NaCl in series up
to 10−7 and 2 drops of 20 𝜇L of each dilution were inoculated
on BHI agar (BD, Sparks, USA) to determine the number of
viable microorganisms and assess the successfulness of the
sonication procedure [25].The plates were incubated for 24 h
at 37∘C and 10% CO
2
(IG 150, Jouan incubator). CFU were
counted and the results were expressed as CFU/mg of biofilm
dry weight [24].
2.8. Statistical Analysis. The descriptive analysis, in statistical
analysis, was carried out presenting measures of position and
dispersion for continuous variable. The level of significance
adopted for the statistical tests was 5%. ANOVA’s test was
used to compare the parameters, considering the factors
used. The variables were transformed into ranks due to the
sample size. Multiple comparisons had been carried through
by the test of Tukey and the test of profile for contrasts. The
Jonckheere-Terpstra test was used for comparing numerical
measures among groups with ordinance and magnitude
(tendency).
Capital letters indicate statistical differences between cul-
ture media (UTYEB, MH, and MHS), and lowercase letters
indicate statistical differences according to the treatments
using each culture medium (UTYEB, MH, or MHS), by
ANOVA and Tukey tests (𝑝 < 0.05). The software SPSS
for Windows 10.0 (SPSS, Chicago, IL, USA) was used for
statistical analysis.
3. Results
A statistically significant tendency effect (𝑝 ≤ 0.002)
was found among CHX concentration, biofilm dry weight,
and viable bacteria, showing dose-response effect on these
variables using UTYEB, MH, or MHS. It was observed that
although the amount of biofilm and viable microorganisms
formed on glass microscope slides using MH medium was
lower, blood did not result in difference between them (MH
or MHS).
Biofilms formed on MH or MHS medium presented
lower dry weight values than UTYEB (𝑝 < 0.0001). Using
UTYEB, only the dry weight of the biofilm treated with 0.12%
CHX had lower values than other groups and same values as
baseline 48 h (𝑝 < 0.0001). Using MH or MHS, lower values
of dryweightwere found in the groups 0.12%CHXor baseline
48 h than in groups treated with 0.0001% CHX or baseline
120 h. However, in groups treated with 0.012% CHX, 0.001%
did not differ from others (𝑝 = 0.0005) (Table 1 and Figure 2).
Concerning the viable bacteria (UFC), biofilms formed
onMHorMHSmediumpresented lower values thanUTYEB
(𝑝 < 0.0001). Using UTYEB, viable bacteria of the biofilm
treated with 0.12% CHX had lower values than baseline 48 h
group; however, these baselines did not differ from the groups
treated with 0.012%, 0.001%, and 0.0001% CHX. Baseline
120 h group presents higher values (𝑝 < 0.0001). Using MH
orMHS, lower values of UFC were found in the group 0.12%,
0.012% CHX, or baseline 48 h compared to those in groups
treated with 0.0001% CHX or baseline 120 h. Yet, the groups
treated with 0.001% CHX did not differ from the others (𝑝 <
0.0001) (Table 2 and Figure 3).
MH medium, with or without blood, was more sensitive
to show biofilm differences in the viable bacteria/mg dry
weight, when compared to protocol using UTYEB medium
(Table 3 and Figure 4), decreasing the biofilm capacity to
produce acids (Figures 5, 6, and 7). Using UTYEB the
concentration of 0.012% CHX or lower had a bacteriostatic
effect, not interfering with the dry weight and viable bacteria
counts, but affecting the acid production level, which was
lower than that of the control group.
Biofilms formed on MH or MHS medium presented
lower values of the biomass (viable microorganisms/mg dry
weight) than UTYEB (𝑝 < 0.0001). Using UTYEB, the
biomass of biofilm treated with 0.12% CHX showed lower
values than other groups, and baseline 120 h presented the
higher values. Using MH or MHS, lower values were found
in the groups treated with 0.12% CHX, which was lower than
0.012% CHX group and this was lower than 0.001% CHX
group. The group treated with 0.0001% CHX and baselines
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Table 1: % means and standard deviations of dry weight in the biofilms growth according to the treatments.
Groups Dry weight (mg)
MH MHS UTYEB
Baseline 48 h 2.13 (1.03)Ba 2.25 (0.29)Ba 3.05 (0.26)Bb
Baseline 120 h 1.75 (0.29)Ba 2.50 (0.82)Ba 20.49 (9.51)Aa
CHX 0.0001% 2.00 (0.18)Ba 2.23 (0.39)Ba 15.20 (5.02)Aa
CHX 0.001% 1.48 (0.31)Cab 1.98 (0.74)Cab 18.04 (5.42)Aa
CHX 0.012% 1.43 (0.37)Cab 1.10 (0.23)Cab 13.19 (2.05)Aa
CHX 0.12% 0.75 (0.29)Cb 0.88 (0.25)Cb 2.30 (0.82)Bb
Means within lines followed by distinct capital letters and those in columns followed by lower case letters differ statistically by Tukey test (𝑝 < 0.05).
Table 2: % means and standard deviations of viable bacteria (CFU) in the biofilms growth according to the treatments.
Groups CFU
MH MHS UTYEB
Baseline 48 h 1.03E + 08 (1.44E + 07)Aa 1.25E + 08 (1.00E + 07)Aa 4.50E + 07 (1.41E + 07)Ab
Baseline 120 h 8.17E + 07 (1.01E + 07)Aa 1.00E + 08 (4.77E + 07)Aa 5.46E + 08 (5.89E + 07)Aa
CHX 0.0001% 8.17E + 07 (2.93E + 07)Aa 9.83E + 07 (5.43E + 07)Aa 3.60E + 08 (4.34E + 07)Aab
CHX 0.001% 5.67E + 06 (8.78E + 05)Bab 7.42E + 06 (2.93E + 06)Bab 3.39E + 08 (4.16E + 07)Aab
CHX 0.012% 8.92E + 05 (8.04E + 04)Bb 9.17E + 05 (3.82E + 04)Bb 1.60E + 08 (5.88E + 07)Aab
CHX 0.12% 8.33E + 02 (2.89E + 02)Cc 8.58E + 02 (8.43E + 02)Cc 1.58E + 02 (5.20E + 01)Cc
Means within lines followed by distinct capital letters and those in columns followed by lower case letters differ statistically by Tukey test (𝑝 < 0.05).
Table 3: % means and standard deviations of CFU/mg dry weight in the biofilms grown according to the treatments.
Groups CFU/dry weight
MH MHS UTYEB
Baseline 48 h 5.50E + 07 (2.70E + 07)Aa 5.47E + 07 (6.82E + 06)Aa 1.63E + 07 (5.36E + 06)Ab
Baseline 120 h 4.04E + 07 (8.72E + 06)Aa 4.82E + 07 (3.76E + 07)Aa 3.24E + 07 (1.76E + 07)Aa
CHX 0.0001% 3.51E + 07 (9.75E + 06)Aa 4.84E + 07 (2.72E + 07)Aa 2.26E + 07 (8.37E + 06)Ab
CHX 0.001% 4.52E + 06 (7.75E + 05)Bb 4.28E + 06 (1.74E + 06)Bb 1.98E + 07 (6.18E + 06)Ab
CHX 0.012% 7.94E + 04 (1.07E + 04)Cc 8.65E + 05 (2.29E + 05)Cc 1.07E + 07 (2.79E + 06)Ab
CHX 0.12% 1.03E + 03 (7.76E + 02)Cd 1.02E + 03 (7.59E + 02)Cd 1.20E + 03 (2.23E + 03)Cc
Means within lines followed by distinct capital letters and those in columns followed by lower case letters differ statistically by Tukey test (𝑝 < 0.05).
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Figure 2: % means and standard deviations of dry weight in the
biofilms growth according to the treatments. Capital letters indicate
statistical differences between culture media, and lowercase letters
indicate statistical differences according to the treatments using each
culture medium, by Tukey test (𝑝 < 0.05).
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Figure 3: %means and standard deviations of viable bacteria (CFU)
in the biofilms growth according to the treatments. Capital letters
indicate statistical differences between culture media, and lowercase
letters indicate statistical differences according to the treatments
using each culture medium, by Tukey test (𝑝 < 0.05).
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using each culture medium, by Tukey test (𝑝 < 0.05).
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Figure 5: pHof theMHculturemediumafter 48 h of biofilmgrowth
in the absence of treatments and at each 24 h after starting treatments
(72, 96, and 120 h) (𝑛 = 4).
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Figure 6: pH of the MHS culture medium after 48 h of biofilm
growth in the absence of treatments and at each 24 h after starting
treatments (72, 96, and 120 h) (𝑛 = 4).
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Figure 7: pH of the UTYEB culture medium after 48 h of biofilm
growth in the absence of treatments and at each 24 h after starting
treatments (72, 96, and 120 h) (𝑛 = 4).
48 h and 120 h presented higher values than the others (𝑝 <
0.0001) (Table 3).
At all times, using MH, with or without blood (Figures
5 and 6), group 0.12% CHX showed higher pH than group
0.012% CHX, which showed higher pH than 0.0010% CHX,
and those groups presented higher pH than other groups.
However, using UTYEB, only the group 0.12% CHX showed
higher pH than group 0.012% CHX and those groups pre-
sented higher pH than others (Figure 7).
4. Discussion
The polymicrobial community of dental biofilm is one of
the best-studied kinds of biofilms. When it comes to oral
biofilm, more than 500 species or phylotypes have been
identified [26]. Dental biofilm is challenged by frequent
changes in environmental conditions, for example, food
intake, temperature, pH change, and salivary flow. Perhaps
as a response to environmental challenges, the oral biofilm
community has evolved with individual members assuming
specialized functions, for example, primary and secondary
colonizers [27], including members that can metabolize
excreted products (such as lactic acid) produced by other
species [28].
It is challenging to control diseases caused by biofilms due
to the difficulty in finding substances able to interfere with
factors involved with bacterial organization in a biofilm, as
well as the antibacterial properties of the biofilm structure
itself [29]. Antiplaque agents are designed to (a) prevent
the formation of the biofilm and/or (b) remove established
biofilm. In contrast, the mode of action of antimicrobial
agents involves inhibiting the growth or killing the target bac-
teria, expressed in terms of their MIC or MBC, respectively
[30].
There are currently a variety of model systems available
that could be applied for studying the process of human
dental caries, each of these showing advantages and disad-
vantages. An in vitro model system using bacterial biofilms
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is likely to display less inherent variability than an in situ
model system, since variables such as fluid (saliva) flow,
carbohydrate intake, and bacterial population composition
can be controlledmore accurately in vitro [31].Themodel of S.
mutans biofilm growth tested in this study, described by Koo
et al. [22] and modified by Ccahuana-Va´squez and Cury [23]
using MH, as indicated by CLSI M7-A6 [21], was validated
and the dose-response effect of CHX on S. mutans biofilm
was shown for all variables.
The main relevance of this study is that it used the
standards of the Clinical and Laboratory Standards Institute
(CLSI, formerly NCCLS), an international, interdisciplinary,
nonprofit, standards-developing, and educational organiza-
tion that promotes the development and use of voluntary
consensus standards and guidelines within the healthcare
community. It is recognized worldwide for developing stan-
dards and guidelines for patient testing and related healthcare
issues. Their process is based on the principle that consensus
is an effective and cost-effective way to improve patient
testing and health care services. In addition to developing
and promoting the use of voluntary consensus standards
and guidelines, they provide an open and unbiased forum
to address critical issues affecting the quality of patient and
health care (CLSI M7-A6 [21]).
In the present study, the model using CLSI M7-A6 [21]
protocol showed a lower amount of biofilm and viable
microorganisms formed on glass microscope slides and was
more sensitive than themodel described byKoo et al. [22] and
modified by Ccahuana-Va´squez and Cury [23] in showing
biofilm changes in the presence of antimicrobial substances.
These differences can be supported by the Shemesh et al.
[20] study, which tested some nutrient components and their
influence on gene expression in S. mutans biofilms under
various conditions.
Using differential analysis of the transcripts from S.
mutans growth in media of various nutrient contents they
observed the pivotal role of the dietary in the pathogenicity
of S. mutans biofilm and the influence of such carbohydrates
on gene expression, which can present different responses
to antimicrobial substances, as well as on biofilm thickness.
For both media, the treatment twice a day with 0.12% CHX
showed a bactericidal effect, avoiding the increase in biofilm
mass (dry weight) (Table 1 and Figure 2) and eliminating a
large proportion of the viable bacteria in the biofilm (Table 2
and Figure 3). However, using MH, which has nutrient
content recognized and approved by CLSI M7-A6 [21], the
concentration of 0.012% CHX interfered with the dry weight
and viable bacteria counts and affected the acid production
level, which was lower than that in the control group [32]
(Tables 1–3) (Figures 2–7).
Its mechanism of action includes direct damage to the
internal cytoplasmatic membrane, being bacteriostatic at low
dosages and bactericidal at high concentrations [15]. This
implies that the structural damage caused by 0.012%CHXwas
less than that caused by 0.12% CHX or lower concentrations.
The results found with the use of both models that were
supported by a clinical trial show that 0.12% CHX is more
effective in reducing S. mutans CFU than lower concen-
trations [33]. In spite of that, more studies are necessary
to evaluate the influence of a culture medium on dose-
response effect of the chlorhexidine (CHX) on Streptococcus
mutans UA159 biofilm, formed on enamel slabs, and enamel
demineralization.
5. Conclusions
We can conclude that the culture medium does influence
dose-response effect of chlorhexidine (CHX) on Streptococ-
cus mutans biofilm. The results suggest that MH broth can
be used as an alternative medium for antibacterial activity
without blood supplementation.
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